New stent study aims to keep heart arteries open in routine care
NCT ID NCT03588481
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 1,000 people who receive the DESyne X2 drug-eluting stent to treat narrowed or blocked coronary arteries. Researchers are monitoring how often patients experience serious heart events like death, heart attack, or the need for another procedure. The goal is to see how well the stent works in everyday hospital settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DESyne X2 drug-eluting coronary stent (novolimus-eluting stent)
What this could lead to
If successful, this study could confirm that the DESyne X2 stent is safe and effective for treating blocked coronary arteries in everyday medical practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. The stent is already approved, so this is about real-world performance, not a breakthrough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Hospital
RECRUITINGSeoul, South Korea
Contact
Contact
-
Hallym Hospital
RECRUITINGIncheon, South Korea
Contact
Contact
-
Korea University Guro Hospital
TERMINATEDSeoul, South Korea
-
St.carollo Hospital
TERMINATEDSuncheon, South Korea
-
The Catholic University of Korea Seoul St. Mary's Hospital
WITHDRAWNSeoul, South Korea
-
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
TERMINATEDSeoul, South Korea